Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis (Journal article)

Cholongitas, E./ Papatheodoridis, G. V./ Zappoli, P./ Giannakopoulos, A./ Patch, D./ Marelli, L./ Shusang, V./ Kalambokis, G./ Shirling, G./ Rolando, N./ Burroughs, A. K.

Combined disparity of human leukocyte antigen (HLA)-DR and -DQ between mother and fetus is associated with less severe ulcerative colitis (UC) during pregnancy. We evaluated whether donor-recipient HLA disparity after liver transplantation (LT) affects UC in patients with primary sclerosing cholangitis (PSC). Sixty-nine consecutive patients with PSC underwent LT; all underwent colonoscopy before LT; 48 had UC before and 3 had de novo UC after LT. Clinical and laboratory data, activity and treatment of UC, post-LT cytomegalovirus infection, and disparity of HLA-A, -B, -DR, and -DQ for each donor-recipient pair were evaluated. Pre-LT quiescent UC was present in 26 patients. Post-LT UC activity was evaluated in 36 of 51 patients with UC who had not undergone pre-LT colectomy and who had >12 months' post-LT survival. Of these, 16 were stable, 17 had worsened, and 3 had de novo UC. Seven required colectomy (4 for dysplasia or cancer) after LT. Post-LT cytomegalovirus viremia was neither associated with worse UC activity (P = 0.58) nor de novo UC. Disparity with respect to HLA-A, -B, -DR, and -DQ was found in 58%, 27%, 44%, and 39% donor-recipient pairs, respectively. Post-LT UC course was similar with respect to single HLA disparity. However, disparity in none or only one HLA-DR or -DQ was significantly associated with worse activity compared with patients with disparity at both (65% vs. 0%, P = 0.009). Logistic regression found that the disparity for both -DR and -DQ was the only factor statistically significantly associated with post-LT UC activity. We conclude that disparity in both HLA-DR and -DQ between donor and recipient is associated with stable UC activity after LT.
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adolescent,Adult,Aged,Cholangiocarcinoma/epidemiology,Cholangitis, Sclerosing/*surgery,Colitis, Ulcerative/*immunology,Female,HLA-DQ Antigens/*immunology,HLA-DR Antigens/*immunology,Histocompatibility Testing,Humans,Liver Neoplasms/epidemiology,Liver Transplantation/*immunology,Male,Middle Aged,Postoperative Complications/*immunology,Retrospective Studies,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/22969
ISSN: 1527-6465
Link: http://www.ncbi.nlm.nih.gov/pubmed/17394153
http://onlinelibrary.wiley.com/store/10.1002/lt.21077/asset/21077_ftp.pdf?v=1&t=h0ull8ib&s=c3452dedaa6286ecfed68b7d155f3c6392c99b7c
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Cholongitas-2007-Combined HLA-DR and.pdf92.73 kBAdobe PDFView/Open    Request a copy


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22969
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.